Patents by Inventor Kenneth William Hance

Kenneth William Hance has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antigen Binding Proteins
    Publication number: 20230279106
    Abstract: The present disclosure relates to compositions for treating CD96 mediated diseases, and related methods.
    Type: Application
    Filed: September 2, 2022
    Publication date: September 7, 2023
    Applicant: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
    Inventors: Yan Y. DEGENHARDT, Jun GUAN, Kenneth William HANCE, Peter Joseph MORLEY
  • Antigen binding proteins
    Patent number: 11479607
    Abstract: The present disclosure relates to compositions for treating CD96 mediated diseases, and related methods.
    Type: Grant
    Filed: November 19, 2021
    Date of Patent: October 25, 2022
    Assignee: GlaxoSmithKline Intellectual Property Development Limited
    Inventors: Yan Y. Degenhardt, Jun Guan, Kenneth William Hance, Peter Joseph Morley
  • ANTIGEN BINDING PROTEINS
    Publication number: 20220089728
    Abstract: The present disclosure relates to compositions for treating CD96 mediated diseases, and related methods.
    Type: Application
    Filed: November 19, 2021
    Publication date: March 24, 2022
    Inventors: Yan Y. DEGENHARDT, Jun Guan, Kenneth William Hance, Peter Joseph Morley